Henrik Olsen
Rehaler closes financing round and ramps up clinical study
Financing round of 17 MDKK Proceeds will allow expansion and acceleration of the company’s ongoing clinical registration study in...
top of page
Troels Johansen
Jun 29, 2023
Rehaler A/S announces appointment of Henrik Olsen as new CEO
Rehaler A/S today announces the appointment of Henrik Olsen as its new CEO. He will replace co-founder Troels Johansen, who will continue...
Troels Johansen
Jun 19, 2023
Rehaler receives 19 million DKK from EU to advance innovative migraine treatment towards the market
EU’s EIC Accelerator program has awarded the Danish medtech company Rehaler 11 mDKK (1.48 mEUR) in grant and a further 8 mDKK (1.08 mEUR)...
Troels Johansen
Apr 6, 2022
Rehaler receives 2.18 million DKK from the Danish Innovation Fund for new migraine treatment
The Innovation Fund has awarded Rehaler an Innobooster grant for the large scale clinical trial aiming to validate the effect of the...
Troels Johansen
Dec 1, 2021
Rehaler closes financing round and strengthens Board of Directors
Rehaler closes financing round of 6.1m DKK and strengthens Board of Directors with four experienced profiles.
bottom of page